Profilate HT was provided on a named patient basis in the UK Read more about Profilate HT was provided on a named patient basis in the UK
Over the years the text of the Profilate warning was amended to take account of changes to screening tests, but the final sentence remained unchanged. Read more about Over the years the text of the Profilate warning was amended to take account of changes to screening tests, but the final sentence remained unchanged.
Profilate licensed with the following warning: "This product is prepared from units of human plasma which have been tested and found nonreactive for Hepatitis Associated Antigen. However, it is recognized that presently available methods are not sensitive enough to detect all units of potential infectious plasma and the risk of transmitting hepatitis is still present". Read more about Profilate licensed with the following warning: "This product is prepared from units of human plasma which have been tested and found nonreactive for Hepatitis Associated Antigen. However, it is recognized that presently available methods are not sensitive enough to detect all units of potential infectious plasma and the risk of transmitting hepatitis is still present".
Profilate HT gained market share as a consequence of growing confidence that its technique of "wet heat treatment" reduced, although did not eliminate, the risk of infection with non-A non-B Hepatitis as well as inactivating HIV. Read more about Profilate HT gained market share as a consequence of growing confidence that its technique of "wet heat treatment" reduced, although did not eliminate, the risk of infection with non-A non-B Hepatitis as well as inactivating HIV.
Survey of commercially-produced and NHS-produced Factor 8 concentrates refers to Hemofil, Kryobulin and Profilate as three main products licensed in the UK. Read more about Survey of commercially-produced and NHS-produced Factor 8 concentrates refers to Hemofil, Kryobulin and Profilate as three main products licensed in the UK.
Sales figures for the year ending October 1976 showed that Hemofil and Kryobulin were the most used products, followed by Factorate and Profilate. Read more about Sales figures for the year ending October 1976 showed that Hemofil and Kryobulin were the most used products, followed by Factorate and Profilate.
The levels of onward purchase by regional hospital boards both for Kryobulin and Hemofil were not as expected. Read more about The levels of onward purchase by regional hospital boards both for Kryobulin and Hemofil were not as expected.
Kryobulin and Hemofil, the first products to be licensed for use in the UK, were the subject of a one year central contract for ten million international units between the UK companies importing them and the Department of Health and Social Services and Welsh Office Read more about Kryobulin and Hemofil, the first products to be licensed for use in the UK, were the subject of a one year central contract for ten million international units between the UK companies importing them and the Department of Health and Social Services and Welsh Office
The UK was a marketplace for five main commercial Factor 8 products: Hemofil - manufactured by Hyland Therapeutics, Kryobulin - manufactured by Immuno AG, Profilate - manufactured by Abbott Laboratories and then by Alpha Therapeutic Corporation, Factorate - manufactured by the Armour Pharmaceutical Company, and Koate - manufactured by the Cutter Laboratories Inc. Read more about The UK was a marketplace for five main commercial Factor 8 products: Hemofil - manufactured by Hyland Therapeutics, Kryobulin - manufactured by Immuno AG, Profilate - manufactured by Abbott Laboratories and then by Alpha Therapeutic Corporation, Factorate - manufactured by the Armour Pharmaceutical Company, and Koate - manufactured by the Cutter Laboratories Inc.
Cheaper imported plasma formed the basic material for concentrates distributed into 1977 and 1978. Read more about Cheaper imported plasma formed the basic material for concentrates distributed into 1977 and 1978.